Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Acutus Medical Inc (NQ: AFIB )

0.7254 -0.0146 (-1.97%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 18,655
Open 0.7600
Bid (Size) 0.7200 (29)
Ask (Size) 0.7843 (1)
Prev. Close 0.7400
Today's Range 0.7200 - 0.7600
52wk Range 0.4000 - 1.960
Shares Outstanding 34,607,593
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Acutus Medical, Inc.
Via GlobeNewswire
Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares jumped 318.5% to $18.54 after the company released top-line results from randomized withdrawal period of study C602 of DCCR for Prader-Willi... 
Via Benzinga

Performance

YTD
-47.81%
-47.81%
1 Month
+45.08%
+45.08%
3 Month
-17.57%
-17.57%
6 Month
-4.14%
-4.14%
1 Year
-16.61%
-16.61%

More News

Read More
Acutus Medical: Q1 Earnings Insights
Via Benzinga
Acutus Medical's Earnings: A Preview
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Acutus Medical Reports Second Quarter 2023 Financial Results
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical to Present at the 43rd Annual Canaccord Growth Conference
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical to Announce Second Quarter 2023 Financial Results
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical to Showcase Innovative Cardiac Mapping and Ablation Technologies at HRS 2023
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Reports First Quarter 2023 Financial Results
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical to Announce First Quarter 2023 Financial Results
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Announces Preliminary Unaudited First Quarter 2023 Results
From Acutus Medical, Inc.
Via GlobeNewswire
RECOVER AF Study Reports 91% of First Redo Patients Achieved Freedom from AF at One Year After AcQMap-guided Ablation Therapy
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Reports Fourth Quarter and Full Year 2022 Financial Results
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical to Announce Fourth Quarter and Full Year 2022 Financial Results
From Acutus Medical, Inc.
Via GlobeNewswire
Why Hertz Global Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Acutus Medical, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Late-Breaking ACQFORCE FLUTTER Trial Meets Primary Endpoint for Safety and Efficacy with the First Gold-Tipped Contact Force Sensing Ablation Catheter
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Acutus Medical, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.